Workflow
仟源医药:关于2024年限制性股票激励计划部分限制性股票回购注销完成公告

Core Points - QianYuan Pharmaceutical announced the completion of the repurchase and cancellation of part of its restricted stock incentive plan, involving 60,000 shares [2] - The repurchased shares represent 0.0234% of the company's total shares before the repurchase [2] - The repurchase price was set at 4.73 yuan per share, totaling 286,880.20 yuan, including interest from bank deposits [2] - The funding for the repurchase came from the company's own funds [2] - Following the repurchase, the company's total share capital decreased from 256,168,563 shares to 256,108,563 shares [2]